Loading clinical trials...
Loading clinical trials...
A Multicentre Study on the Effects of Self-administration of Medication During Hospitalization on Medication Safety, Adherence, and Patient Satisfaction in Dutch Hospitals
During hospitalization, medication administration errors (MAEs) occur daily in health care and can lead to serious harm. Improvement of medication safety is a major concern to policymakers and health care workers. Inpatient self-administration of medication (SAM) during hospital admission could be a way to reduce MAEs. Therefore the aim of this study is to determine the effect of inpatient self-administration of medication on the number of medication administration errors during hospitalization.
Objective: the main objective of this study is to determine the effect of inpatient self-administration of medication on the number of medication administration errors during hospitalization. The secondary objectives of this study are to determine: 1. The effect of inpatient self-administration of medication on the severity of medication administration errors during hospitalization 2. The effect of inpatient self-administration on medication adherence after hospitalization 3. The effect of inpatient self-administration of medication on patient satisfaction during hospitalization 4. The effect of inpatient self-administration of medication on staff satisfaction during hospitalization Study design: multicentre prospective quasi-experimental study with a pre-post design Study population: hospitalized ≥ 16 years old patients Intervention: the implementation of self-administration of medication by hospitalized patients. SAM will be compared to standard care. Main study parameters: The primary outcome measure of the study is the proportion of medication administrations with one or more medication administration errors (MAEs). Secondary outcome measures will be: severity of MAEs, medication adherence after hospitalization, patient satisfaction during hospitalization, and staff satisfaction. For all outcome measures the effect of SAM will be compared to standard care. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: all subjects have to fulfil two questionnaires, one during hospitalization and one approximately three months after leaving the studied ward, e.g. hospital discharge or transfer. The subjects that are included in de post study period have to self-administrate medication that's suitable for SAM. The risk of SAM during hospitalization is estimated as the risk patients are at home when using medication. The burden of SAM is classified as low because results of a recent questionnaire shows that admitted patients have the urge to act in SAM schemes.
Age
16 - No limit years
Sex
ALL
Healthy Volunteers
No
Radboudumc
Nijmegen, Gelderland, Netherlands
Sint Maartenskliniek
Ubbergen, Gelderland, Netherlands
MUMC+
Maastricht, Limburg, Netherlands
Jeroen Bosch Ziekenhuis
's-Hertogenbosch, North Brabant, Netherlands
Catharina Ziekenhuis
Eindhoven, North Brabant, Netherlands
ETZ
Tilburg, North Brabant, Netherlands
Groene Hart Ziekenhuis
Gouda, South Holland, Netherlands
Meander Medisch Centrum
Amersfoort, Netherlands
Start Date
December 1, 2018
Primary Completion Date
May 2, 2019
Completion Date
May 2, 2019
Last Updated
September 14, 2020
193
ACTUAL participants
Self-administration of medication (SAM)
BEHAVIORAL
Lead Sponsor
Radboud University Medical Center
Collaborators
NCT04854278
NCT06398860
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions